Standard Dosing Ranges and Starting Protocols Understanding typical dosing ranges provides foundation for developing individualized protocols
S., Earnest, A., Teede, H
Clinical trials show semaglutide produces 15-22% weight loss at therapeutic doses, but individual response varies significantly based on baseline health markers and genetic predispositions
Patients using GLP-1 medications should maintain contact with their Hers provider and a primary care physician to coordinate care, report persistent side effects, and address any signs of dehydration, acute abdominal pain, or thyroid symptoms
While this can help with bowel function, it also fills the stomach quickly when there isn't much room
However, Retatrutide is still considered an investigational compound , and most information about dosage comes from clinical trials rather than widespread medical use